Despite a clear inhibitory effect of FOXA2 suppression on the metastatic activity of SCLC cells in mice, this had no apparent effect on SCLC viability, proliferation in vitro, or subcutaneous tumor growth in vivo. This evidence concerns the gene FOXA2 and small cell lung carcinoma.